|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Chemotherapy induces death receptor 5 in epithelial ovarian carcinoma显示文摘 | Arts H J deJong S Hollema H | 2004 | Gynecol Oncol2004，92，3： | 1 |
| 2 | Predictive effect of p53 and p21 alteration on chemotherapy response and survival in locally advanced adenocarcinoma of the esophagus显示文摘 | Heeren P A Kloppenberg F W Hollema H | 2004 | Anticancer Res2004，24，4： | 1 |
| 3 | Aromatase in the context of breast and endometrial cancer显示文摘 | Jongen VH Hollema H Van Der Zee AG | 2006 | Minerva Endocrino12006，31，1： | 1 |
| 4 | Chemotherapy induces death receptor 5 in epithelial ovarian carcinoma 显示文摘 | Arts HJG de Jong S Hollema H | 2004 | Gynecol Oncol2004，92，： | 1 |
| 5 | Apoptosis and apoptosis-associated parameters in relation to tamoxifen exposure in postmenopausal endometrium显示文摘 | Mourits M Hollema H De Vries E | 2002 | Human Pathol2002，33，3： | 1 |
| 6 | Surgical treatment of recurrent pleomorphic adenoma of the parotid gland: a clincial analysis of 52 patient显示文摘 | GLAS A S VERMEY A HOLLEMA H | 2001 | Head Neck2001，23，4： | 1 |
| 7 | Catecholaminesynthesizing enzymes in carcinoid tumors and pheochromocytomas显示文摘 | Meijer W G Copray S C Hollema H | 2003 | Clin chem2003，49，4： | 1 |
| 8 | Ras/ERK1/ 2-mediated STAT3 Ser727 phosphorylation by familial medullary thyroid carcinoma-associated RET mutants induces full activation of STAT3 and is required for c-fos promoter activation, cell mitogenicity, and transformation 显示文摘 | Plaza-Menacho I van der Sluis T Hollema H | 2007 | J Biol Chem2007，282，9： | 1 |
| 9 | Structral alterations of transforming growth factor beta receptor genes in human cervical carcinoma显示文摘 | De Vries EG Hollema H ea al | 1999 | Int J Cancer1999，282，1： | 1 |
| 10 | The impor-tance of the groin node status for the survival of T1 andT2 vulval carcinoma patients显示文摘 | Burger MP Hollema H Emanuels AG | 1995 | Gynecol Oncol1995，57，3： | 1 |
| 11 | Expression of cyclo-oxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages显示文摘 | Klimp AH Hollema H Kempinga C | 2001 | Cancer Res2001，61，： | 1 |
| 12 | Apoptosis and apoptosis-associated parameters in relation to tamoxifen exposure in postmenopausal endometrium显示文摘 | Mourits M Hollema H De Vries E | 2002 | Human Pathol2002，33，3： | 1 |
| 13 | Monoclonal antibodies (MT1, MT2, MB1, MB2, MB3) reactive with leukocyte subsets in paraffin-embedded tissue sections 显示文摘 | Poppema S Hollema H Visser L | 1987 | Am J Pathol1987，127，： | 1 |
| 14 | Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva显示文摘 | de Hullu JA Hollema H Piers DA | 2000 | JClinOnc2000，18，15： | 1 |
| 15 | Serum CA125,carcinoembryonic antigen,and CA199 as tumor markers in borderline ovarian tumors显示文摘 | Engelen MJ de Bruijn HW Hollema H | 2000 | Gynecol Oncol2000，78，1： | 1 |
| 16 | Telomerase in relation to expression of p53, c-Myc and estrogen receptor in ovarian tumou~ 显示文摘 | Wisman GB Hollema H Helder MN | 2003 | Int J Oncd2003，23，5： | 1 |
| 17 | Catecholamine-synthesizing enzymes in carcinoid tumors and pheochromocytomas显示文摘 | Meijer WG Copray SC Hollema H | 2003 | Clin Chem2003，49，4： | 1 |
| 18 | Chemotherapy induces death receptor 5 in epithelial ovarian carcinoma 显示文摘 | ARTS H J DE JONG S HOLLEMA H | 2004 | Gynecol Oncol2004，92，3： | 1 |
| 19 | Serum CA125,carcinoembryonic antigen,and CA19-9as tumor markers inborderline ovarian tumors显示文摘 | Engelen MJ de Bruijin HW Hollema H | 2000 | Gynecol Oncol2000，78，1： | 1 |
| 20 | The distribu- tion of drug - efflux pump, R - gp, BCRP, MRP1 and MRP2,in the normal blood - tesyis barrier and in pri- mary testicular tumours 显示文摘 | BART J HOLLEMA H GROEN J | 2004 | Eur J Cancer2004，40，14： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员